The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Did IMM continue to give the drug to patients who want to continue the treatment after the trial? Many were pleading to continue because it works for them with no side effect. Eventually this will be an approved winning drug, just got to get through the statistical protocol.
The company has an obligation to update the market before opening on Monday. The nomad will insist on this under market abuse regulations(MAR).
I believe it will either be positive news or a further extension date. Either way I am relaxed . Medium term this share is a star performer.
Are you sure?? Receivables rising..very odd . Director sale one week ago. Binary options revenue now zero. 51% of Bet90, marketing spend needed. Very little cash. I would say overbought!! Where is the revenue coming from. Terrible critique on internet.
Something is beginning to stir now. 40 trades this morning and new comment on speaking to pharmaceuticals . When the herd return this will rocket. I am a realist. This company is so oversold it is hard to believe...just look at the rest of their portfolio even without lupus.
I agree Geeforce. The client base of the company is blue chip and top quality. To have a market cap of £12.00m only at this point seems to me to be derisory. This share has an exciting time ahead.
Early interim rise is my bet. This share is undervalued, it is extraordinary. ...on fundamentals, balance sheet, market position and takeover target we should be several multiples of current price.
I agree that it was a huge overreaction to the recent RNS. The drug will be reformulated and needs some tweaks. It will be produced , just need to work out optimum algorithm.
Takeover chat could be starting to develop. If so.....what a bargain price!!!!!!!!!!
Elegance, you are correct. Let�s kick a lot of the nonsense on these bb�s in to the long grass. This share is ,in my view, now one of the best recovery plays on the market. It is massively oversold.
Chairman is highly encouraged. So should we be. I hope this wipes out some of the nonsensical posts that have appeared on here recently. IMM at these levels is a great recovery stock.
With a market cap of �20.0m this seems to me to still be a major bargain. It is likely with these views that this will attract an international media corporation. �20.0m to them is petty cash. Take your own view but with 4.6B views in April, way ahead of three months ago, this should command more like �200m.
With this reach and influence , BBSN has got to be one of the most undervalued shares on AIM. I would anticipate that an international corporation may well want to buy their market share and , if so, it would be at many times their market capitalisation of ,believe it or not, only �5.00m. What a great RNS.
A takeover does not have to be agreed, only an approach that may or may not lead to an offer. So an RNS could come any time. I am sure the BOD are weighing up various alternative strategies. Individual shareholder speculation is facile.
A very good message from you Richardo. I have long experience in this game. A takeover/ jv is imminent, Twice as many buys as sells today is the first signal. Shorters should be v careful now.
Excellent post from bots. This is the view of a pragmatic investor, not short term trader. Long term I believe this will come good with some form of partnership, financial or commercial, or alternatively a take over. Patience will almost certainly pay off.
There has been a lot of interesting comment this morning on how the market makers are playing the private investors but not much discussion on the fundamentals of the business. It seems to me that the business is growing steadily with a strong revenue growth. A regular flow of new games and updates plus some interesting commercial relationships in Myanmar. Also a financing CLN which converts at 3p. All in all I see this as a great level to invest. Time will tell but whilst day traders may be disappointed, I have a feeling long term investors will be rewarded.
Why does the company need cash so badly? The IPO was les than three months ago and all involved, including Nomad, reporting accountants and Board signed off on 12 months available working capital. It feels to me like a heavily oversold share.